This is a list of all the questions and their associated study carrel identifiers. One can learn a lot of the "aboutness" of a text simply by reading the questions.
identifier | question |
---|---|
cord-011189-c0ytamge | International study of the prevalence and outcomes of infection in intensive care units Ready for a world without antibiotics? |
cord-009967-fyqc5bat | This is medical progress? |
cord-016187-58rqc0cg | -The lessons of SARS Public health measures to control the spread of the severe acute respiratory syndrome during the outbreak in Toronto Multistate outbreak of monkeypox- Illinois Westward HO? |
cord-016187-58rqc0cg | -The spread of West Nile virus Death from the Nile crosses the Atlantic: The West Nile fever story Hemorrhagic fever viruses as biological weapons Death due to bioterrorism- related anthrax: Report of two patients Isolation and partial molecular characterization of a strain of Ebola virus during a recent epidemic of viral haemorrhagic fever in Gabon Staphylococcus aureus resistant to Vancomycin- United States Oseltamivir- resistant infl uenza? |
cord-308480-t2vukbwp | Why are oseltamivir and zanamivir effective against the newly emerged influenza A virus( A/ H1N1)? |
cord-295605-c6z9n3ij | A Study of The Common Cold-Principles of Judicious Use of Antimicrobial agents Rheumatic heart disease-a challenge Febrile exudative tonsillitis: viral or streptococcal? |
cord-018566-dd5gw66t | The landscape of antibiotic resistance Prepared for United States Department of Health and Human Services, Public Health Service, Food and Drug Administration, Bureau of Veterinary Medicine Prudent use and regulatory guidelines for veterinary antibiotics- politics or science? |
cord-279483-gwikyux2 | Can clinical prediction models assess antibiotic need in childhood pneumonia? |
cord-011310-fm578rm5 | 2nd Consultation of Member States and Partners on the Global Development and Stewardship Framework to What is antimicrobial stewardship? |
cord-011310-fm578rm5 | How far are we from vaccination against Helicobacter pylori infection? |
cord-011310-fm578rm5 | Mean in Terms of Antibiotic Consumption? |
cord-255635-0pr9oae6 | -what is it all about? |
cord-289382-bnl9i9oy | : a molecular, biological, and epidemiological study Has the era of untreatable infections arived? |
cord-289382-bnl9i9oy | Where can I go for more information? |
cord-289382-bnl9i9oy | where does it come from and what can we do about it? |
cord-267023-w5ig7mrl | ( 1) Were antibiotics indicated for a"true infection"( no alternative noninfectious primary diagnosis)? |
cord-267023-w5ig7mrl | ( 2) Did the"selected regimen"cover the infection and pathogens in question? |
cord-267023-w5ig7mrl | ( 3) Were antibiotic"dose"and"duration"appropriate? |
cord-267023-w5ig7mrl | : how are we educating our future prescribers? |
cord-267023-w5ig7mrl | performance, education and knowledge Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America guidelines for developing an institutional program to enhance antimicrobial stewardship New societal approaches to empowering antibiotic stewardship CMS Issues Proposed Rule that Prohibits Discrimination, Reduces Hospital- Acquired Conditions, and Promotes Antibiotic Stewardship in Hospitals Health care provider education as a tool to enhance antibiotic stewardship practices Is there an app for that? |
cord-013105-tmhce7p5 | And where critically ill patients are most commonly located? |
cord-013105-tmhce7p5 | How can this be done? |
cord-013105-tmhce7p5 | What health- care providers who take care of critically ill patients( emergency department physicians, intensivists, anesthesiologists, pulmonologists, infectologists, clinicians and surgeons) can do to curb the fate of antibiotic loss? |
cord-013105-tmhce7p5 | Which patients end up receiving the majority of empiric intravenous antibiotics? |
cord-013105-tmhce7p5 | tmhce7p5 nan administration of antibiotics, is the accelerating drive of bacterial resistance- then, a begging question must be answered: Who is responsible for most intravenous antibiotic use? |
cord-259945-nmjwzk4e | : Smucny JJ, Becker LA, Glazier RH, McIsaac W. Are antibiotics effective treatment for acute bronchitis? |
cord-259945-nmjwzk4e | What will it take to stop physicians from prescribing antibiotics in acute bronchitis? |
cord-259945-nmjwzk4e | results of U.S. and European trials of antibiotic therapy Is an objective assessment of antibiotic therapy in exacerbations of chronic bronchitis possible? |
cord-017393-kx8kmdej | Can antibacterial therapy be discontinued in persistently febrile granulocytopenic cancer patients? |
cord-017393-kx8kmdej | Echinocandins-first- choice or first- line therapy for invasive candidiasis? |
cord-017393-kx8kmdej | Is there agreement? |
cord-017393-kx8kmdej | The identification of febrile, neutropenic children with neoplastic disease at low risk for bacteremia and complications of sepsis Fever control in septic shock: beneficial or harmful? |
cord-017393-kx8kmdej | b lactam monotherapy versus b lactam- aminoglycoside combination therapy for fever with neutropenia: systematic review and meta- analysis Aminoglycosides: single or multiple daily dosing? |
cord-282628-6uoberfu | How do the virulence factors of shigella work together to cause disease? |
cord-282628-6uoberfu | What is flux balance analysis? |
cord-257244-gryp0khc | Does the use of antibiotics in early childhood increase the risk of asthma and allergic disease? |
cord-310474-hip7t0jx | Developments and Directions Gram- Negative Bacterial Lysins Metal Complexes, an Untapped Source of Antibiotic Potential? |
cord-297125-la20vi9j | : are we a threat to each other? |
cord-297125-la20vi9j | People's republic of China Future vaccines for a globalized world First Blue Bell ice cream, now Sabra hummuswhy all the food recalls lately? |
cord-297125-la20vi9j | Why is big pharma getting out of antibacterial drug discovery? |
cord-297125-la20vi9j | impacts of river discharge and aquaculture activities Does the recent growth of aquaculture create antibiotic resistance threats different from those associated with land animal production in agriculture? |
cord-018557-iuu38yes | Does culture confirmation of high- sensitivity rapid streptococcal tests make sense? |
cord-018557-iuu38yes | Does this patient have sinusitis? |
cord-018557-iuu38yes | Follow- up visit after acute otitis media Treatment of recurrent otitis media after a previous treatment failure: Which antibiotics work best? |
cord-018557-iuu38yes | Report from International Primary Care Network Diagnosis and management of acute otitis media Trends in doctor consultations, antibiotic prescription and specialist referrals for otitis media in children Trends in otitis media treatment and relapse National trends in emergency department antibiotic prescribing in children with acute otitis media Otitis media in children: To treat or not to treat? |
cord-018557-iuu38yes | The end of antibiotic treatment in adults with acute sinusitis- like complaints in general practice? |
cord-018557-iuu38yes | The use of antibiotics and bronchodilators Are antibiotics effective treatment for q acute bronchitis? |
cord-018557-iuu38yes | Transmission of the viruses and susceptibility of the population Viruses causing common respiratory infections in man Viruses and bacteria in the etiology of the common cold Antibiotics and upper respiratory infection: Do some folks think there is a cure for the common cold? |
cord-018557-iuu38yes | Who needs post treatment follow- up? |
cord-275700-tx4hirm4 | Are patients more satisfied when expectations are met? |
cord-275700-tx4hirm4 | How do we achieve cost- effective options in lower respiratory tract infection therapy? |
cord-275700-tx4hirm4 | Kentucky and Tennessee Are antibiotics effective treatment for acute bronchitis? |
cord-027860-s97hdhh6 | ( Do I have cold sores? |
cord-027860-s97hdhh6 | Do I have genital herpes? |
cord-027860-s97hdhh6 | How should this change the way I live my life?). |
cord-027860-s97hdhh6 | The lesions are most Who to Screen? |
cord-027860-s97hdhh6 | The question,"Do you regularly use condoms?"has little relevance to infection control for many sexual practices. |
cord-286574-t9z2ynt5 | Active surveillance based on MDR gram- negative pathogens? |
cord-286574-t9z2ynt5 | Epidemiology and management of mucormycosis and invasive aspergillosis: are there lessons to be learned? |
cord-286574-t9z2ynt5 | What is the proper volume of resuscitating fluid and how to monitor are also important issues we should have interest? |
cord-286574-t9z2ynt5 | What to use in the clinical practice? |
cord-312266-hnbgaxft | >/= 60 years: 3 years of follow- up in the CAPAMIS study 23-valent pneumococcal polysaccharide vaccine( PPV23) for the prevention of invasive pneumococcal diseases( IPDs) in the elderly: is it really effective? |
cord-312266-hnbgaxft | what works and at what cost? |
cord-308001-gkd9d3k0 | -Is it fit for purpose? |
cord-308001-gkd9d3k0 | : What is AGREEd? |
cord-308001-gkd9d3k0 | How Our Population Is Changing and Why It Matters; Office for National Statistics Antibiotics in primary care in England: Which antibiotics are prescribed and for which conditions? |
cord-308001-gkd9d3k0 | What's a Good Response Rate? |
cord-306600-cxz8hf9q | The co- pathogenesis of influenza viruses with bacteria in the lung Mucosal administration of flagellin induces innate immunity in the mouse lung Flagellin promotes myeloid differentiation factor 88-dependent development of Th2-type response Lung epithelial cells: therapeutically inducible effectors of antimicrobial defense Lung epithelial MyD88 drives early pulmonary clearance of Pseudomonas aeruginosa by a flagellin dependent mechanism Understanding the pneumococcus: transmission and evolution Antibiotic resistance and its cost: is it possible to reverse resistance? |
cord-306600-cxz8hf9q | When does 2 plus 2 equal 5? |
cord-351231-aoz5jbf1 | The spirochetal etiology of Lyme disease Interview with Willie Bergdorfer, Ph.D. Interview by Vicki Glaser Lyme disease- a tick- borne spirochetosis? |
cord-322915-zrjx31ev | : where did we go wrong? |
cord-322915-zrjx31ev | The end of an era? |
cord-322915-zrjx31ev | The future of cephalosporins business Infectious history Oceans: medicine chests of the future? |
cord-322915-zrjx31ev | Where have all the antibiotic patents gone? |
cord-304972-aktfbriw | Are any of the following criteria present? |
cord-304972-aktfbriw | Does this patient have strep throat? |
cord-304972-aktfbriw | Qué papel tiene la otorrinolaringología en la asistencia primaria? |
cord-304972-aktfbriw | Which treatments provide the most relief for pharyngitis pain? |
cord-307429-ll109j3i | A review of Streptococcus pneumoniae infection treatment failures associated with fluoroquinolone resistance Changing trend of antimicrobial resistance and serotypes in Streptococcus pneumoniae in Asian countries: an ANSORP study Penicillins for treatment of pneumococcal pneumonia: does in vitro resistance really matter? |
cord-307429-ll109j3i | Antibiotic use in Vietnamese hospitals: a multicenter point- prevalence study Antimicrobial resistance: global report on surveillance Unnecessary antibiotic use for mild acute respiratory infections during 28-day follow- up of 823 children under five in rural Vietnam Consumers and providers- Could they make better use of antibiotics? |
cord-307429-ll109j3i | Australia Government( AMR) Antibiotic use: how to improve it? |
cord-307429-ll109j3i | Does the adoption of EUCAST susceptibility breakpoints affect the selection of antimicrobials to treat acute community- acquired respiratory tract infections? |
cord-307429-ll109j3i | Garrod Lecture: EUCAST- are we heading towards international agreement? |
cord-307429-ll109j3i | Macrolide- resistant Mycoplasma pneumoniae in adults in Zhejiang, China Macrolide resistance of Mycoplasma pneumoniae Emergence of macrolide- resistant Mycoplasma pneumoniae in Hong Kong is linked to increasing macrolide resistance in multilocus variable- number tandem- repeat analysis type 4- 5- 7- 2 Epidemiology and clinical manifestations of children with macrolide- resistant Mycoplasma pneumoniae pneumonia in Taiwan Molecular characterizations of PCR- positive Mycoplasma pneumoniae specimens collected from Australia and China Mycoplasma pneumoniae infections- Does treatment help? |
cord-307429-ll109j3i | What can be done about the private health sector in low- income countries? |
cord-317410-hc06yo32 | What are the clinical scoring tools to diagnose group A streptococcal pharyngotonsillitis? |
cord-317410-hc06yo32 | What are the sensitivity and specificity of the Centor scoring system? |
cord-317410-hc06yo32 | What are the treatment and diagnosis of group A streptococcal pharyngotonsillitis in primary care practice? |
cord-317410-hc06yo32 | What is the prevalence of group A streptococcal pharyngotonsillitis among children and adults worldwide? |
cord-317410-hc06yo32 | What is the principle of management for antibiotic prescription in primary care clinics? |
cord-252243-ua2w6xki | Different members of staff have audited different topics, have n't you? cord-252243-ua2w6xki I think sepsis has to be first, does n't it? |
cord-252243-ua2w6xki | An Interrupted Time Series Analysis Antibiotics in primary care in England: Which antibiotics are prescribed and for which conditions? |
cord-252243-ua2w6xki | Int: how would you diagnose a suspected UTI over the phone versus in face to face consultation? |
cord-252243-ua2w6xki | It's the trump card, is it?" |
cord-252243-ua2w6xki | So what determines whether they get sent for culture? |
cord-252243-ua2w6xki | We have our own internal audits and most of you do an audit for your appraisals and things as well do n't you?" |
cord-252243-ua2w6xki | Why did some practices not implement new antibiotic prescribing guidelines on urinary tract infection? |
cord-252243-ua2w6xki | can you make sure you keep a clean catch? |
cord-252243-ua2w6xki | like with coughs and colds everyone knows now that they're not going to get an antibiotic necessarily, they've braced themselves for the bad news, have n't they? |
cord-252243-ua2w6xki | why have you dropped it off?" |
cord-292094-vmsdhccp | : a meta- analysis Is the lateral decubitus radiograph necessary for the management of a parapneumonic pleural effusion? |
cord-292094-vmsdhccp | A framework for improvement Do guidelines for community- acquired pneumonia improve the cost- effectiveness of hospital care? |
cord-292094-vmsdhccp | How should we make the admission decision in community- acquired pneumonia? |
cord-292094-vmsdhccp | Predicting bacteremia in patients with community- acquired pneumonia Diagnosing pneumonia by physical examination: relevant or relic? |
cord-292094-vmsdhccp | The burden of community- acquired pneumonia in seniors: results of a population- based study Mortality from invasive pneumococcal pneumonia in the era of antibiotic resistance, 1995- 1997 Guidelines for community- acquired pneumonia: are they reflected in practice? |
cord-292094-vmsdhccp | What factors influence physicians'decisions to switch from intravenous to oral antibiotics for community- acquired pneumonia? |
cord-292094-vmsdhccp | Why do n't physicians follow clinical practice guidelines? |
cord-292094-vmsdhccp | an international derivation and validation study Community- acquired pneumonia requiring hospitalization: 5-year prospective study outcome and prognostic factors in community- acquired pneumonia requiring hospitalization Appropriateness of hospitalization of patients with community- acquired pneumonia Assessing prognosis and selecting an initial site of care for adults with community- acquired pneumonia Effect of increasing the intensity of implementing pneumonia guidelines: a randomized, controlled trial Community acquired pneumonia: aetiology and usefulness of severity criteria on admission Use of prognostic scoring and outcome assessment tools in the admission decision for community- acquired pneumonia Assessment of illness severity in community acquired pneumonia: a useful new prediction tool? |
cord-292094-vmsdhccp | analysis of two double- blind studies of patients with methicillin- resistant Staphylococcus aureus nosocomial pneumonia Subinhibitory concentrations of linezolid reduce Staphylococcus aureus virulence factor expression American Thoracic Society/ Centers for Disease Control and Prevention/ Infectious Diseases Society of America: controlling tuberculosis in the United States Anti- inflammatory effects of macrolides- an underappreciated benefit in the treatment of community- acquired respiratory tract infections and chronic inflammatory pulmonary conditions? |
cord-292094-vmsdhccp | implications for the treatment of patients with community- acquired pneumonia Streptococcus pneumoniae in community- acquired pneumonia: how important is drug resistance? |
cord-257460-e6anaxck | A meta- analysis Beta 2-agonists for acute bronchitis Do inhaled beta- agonists control cough in URI's or acute bronchitis? |
cord-257460-e6anaxck | A pragmatic randomized double- blind controlled trial in family practice Are antibiotics beneficial for patients with sinusitis complaints? |
cord-257460-e6anaxck | Do antibiotics improve outcomes on chronic rhinosinusitis? |
cord-257460-e6anaxck | Performance characteristics of clinical diagnosis, a clinical decision rule, and a rapid influenza test in the detection of influenza infection in a community sample of adults Computed tomographic study of the common cold Antibiotics for the common cold and acute purulent rhinitis Antibiotics and respiratory infections: are patients more satisfied when expectations are met? |
cord-257460-e6anaxck | The relation between purulent manifestations and antibiotic treatment of upper respiratory tract infections Does this patient have community acquired pneumonia? |
cord-257460-e6anaxck | The role of computed tomography and magnetic resonance imaging in patients with sinusitis with complications Does amoxicillin improve outcomes in patients with purulent rhinorrhea? |
cord-333950-e0hd3iuu | : what is on patient hands and in their rooms? |
cord-333950-e0hd3iuu | A risk assessment approach to the use of disinfectant procedures in the community Too Clean or Not Too Clean? |
cord-333950-e0hd3iuu | Are vancomycin resistant enterococci( VRE) normal inhabitants of the GI tract of hospitalized patients? |
cord-333950-e0hd3iuu | Does the use in animals of antimicrobial agents, including glycopeptide antibiotics, influence the efficacy of antimicrobial therapy in humans? |
cord-333950-e0hd3iuu | How long do nosocomial pathogens persist on inanimate surfaces? |
cord-312417-li41ng7v | Antibiotic resistance? |
cord-312417-li41ng7v | Antimicrobial resistance as a problem of values? |
cord-312417-li41ng7v | Evaluation of antibiotic susceptibility in wound infections: a pilot study from Bangladesh Patient- centred access to health care: conceptualising access at the interface of health systems and populations Changing health- seeking behaviour in Matlab, Bangladesh: do development interventions matter? |
cord-312417-li41ng7v | Front Public Health Antimicrobial resistance, inflammatory responses: a comparative analysis of pathogenicities, knowledge hybrids and the semantics of antibiotic use Help seeking for antibiotics; is the influence of a personal social network relevant? |
cord-312417-li41ng7v | The threat of antimicrobial resistance in developing countries: causes and control strategies Addressing the unknowns of antimicrobial resistance: quantifying and mapping the drivers of burden Antimicrobial resistance-moving forward? |
cord-312417-li41ng7v | To sell or not to sell; the differences between regulatory and community demands regarding access to antibiotics in rural Ghana Community knowledge and practices regarding antibiotic use in rural Mozambique: where is the starting point for prevention of antibiotic resistance? |
cord-312417-li41ng7v | What can"thematic analysis"offer health and wellbeing researchers? |
cord-312417-li41ng7v | What influences antibiotic sales in rural Bangladesh? |
cord-312417-li41ng7v | What is the role of informal healthcare providers in developing countries? |
cord-312417-li41ng7v | Who knows? |
cord-312417-li41ng7v | a systematic review Paying out of pocket for healthcare in Bangladesh-a burden on poor? |
cord-297216-1b99hm1e | A Cultural History Innate Immunity and Asthma Risk in Amish and Hutterite Farm Children Relating Urban Biodiversity to Human Health With the'Holobiont Does Soil Contribute to the Human Gut Microbiome? |
cord-297216-1b99hm1e | A New Vision of Immunity: Homeostasis of the Superorganism Has the Microbiota Played a Critical Role in the Evolution of the Adaptive Immune System? |
cord-297216-1b99hm1e | Can Big Data and Predictive Analytics Deliver Precision Public Health? |
cord-297216-1b99hm1e | Globally Multidrug- Resistant Candida Auris:'New Kid on the Block'in Hospital- Associated Infections? |
cord-297216-1b99hm1e | Humans Increasing Bacterial Evolvability? |
cord-297216-1b99hm1e | If this is indeed true, then could microbes also be critical for mental health? |
cord-297216-1b99hm1e | The Global Need for Effective Antibiotics: Challenges and Recent Advances Nonmedical Uses of Antibiotics: Time to Restrict Their Use? |
cord-297216-1b99hm1e | The Imaginary of Precision Public Health Will Precision Medicine Lead to a Healthier Population? |
cord-297216-1b99hm1e | What if, in addition to protection against allergies and asthma, bacteria were protecting us against mental health conditions such as schizophrenia, bipolar disease, and autism? |
cord-281836-j1r771nq | ( Ace) networks for a Pseudomonas aeruginosa model Antibiotic cycling and antibiotic mixing: which one best mitigates antibiotic resistance? |
cord-281836-j1r771nq | A global view of antibiotic resistance Is El Nino a long- distance corridor for waterborne disease? |
cord-281836-j1r771nq | A new antibiotic kills pathogens without detectable resistance Oxford: University of Oxford in Michaelmas term 1832/ by Individual freedom versus collective responsibility: too many rights make a wrong? |
cord-281836-j1r771nq | Covid-19? |
cord-281836-j1r771nq | Do we need to put society first? |
cord-281836-j1r771nq | Present- day mercury resistance transposons are common in bacteria preserved in permafrost grounds since the Upper Pleistocene Wastewater bacterial communities bring together broad- host range plasmids, integrons and a wide diversity of uncharacterized gene cassettes Limited dissemination of the wastewater treatment plant core resistome Could bacteriophages transfer antibiotic resistance genes from environmental bacteria to humanbody associated bacterial populations? |
cord-281836-j1r771nq | The biological cost of mutational antibiotic resistance: any practical conclusions? |
cord-281836-j1r771nq | The role of natural environments in the evolution of resistance traits in pathogenic bacteria Natural antibiotic resistance and contamination by antibiotic resistance determinants: the two ages in the evolution of resistance to antimicrobials General principles of antibiotic resistance in bacteria Interactions among strategies associated with bacterial infection: pathogenicity, epidemicity, and antibiotic resistance Predicting antibiotic resistance Beyond serial passages: new methods for predicting the emergence of resistance to novel antibiotics What is a resistance gene? |
cord-281836-j1r771nq | What and how should we tell travellers about antimicrobial resistance? |
cord-281836-j1r771nq | a united states perspective Chemical- genetic profiling reveals limited cross- resistance between antimicrobial peptides with different modes of action Global increase and geographic convergence in antibiotic consumption between Extended- spectrum betalactamase- producing Escherichia coli from retail chicken meat and humans: comparison of strains, plasmids, resistance genes, and virulence factors Towards a common definition of global health Abiotic gene transfer: rare or rampant? |
cord-281836-j1r771nq | integrons and gene cassettes between bacterial species Does the recent growth of aquaculture create antibiotic resistance threats different from those associated with land animal production in agriculture? |
cord-281836-j1r771nq | the widespread Pseudomonas aeruginosa Sequence Type 175 international high- risk clone through whole- genome sequencing Hospital effluent: a reservoir for carbapenemase- producing Enterobacterales? |
cord-281836-j1r771nq | turning evolutionary principles into clinical reality Antibiotic resistance and its cost: is it possible to reverse resistance? |
cord-281836-j1r771nq | what's new? |
cord-280158-3fhhuzg5 | Does repeating these strategies boarder on insanity? |
cord-280158-3fhhuzg5 | If indeed antibiotic resistance( mutation- based drug resistance) is the major challenge; then, why have we not focused on identifying drug targets less prone to mutation- based resistance? |
cord-280158-3fhhuzg5 | If indeed mutation- based drug resistance is the greatest impediment to the discovery effort, then why not work backwards from the problem as a discovery strategy? |
cord-280158-3fhhuzg5 | If true, then should we focus efforts on subgroups of pathogens like Gram negative or positive bacteria only, anaerobic bacteria or other group where the range of common essential genes is likely greater?. |
cord-280158-3fhhuzg5 | Is this evolution at work? |
cord-280158-3fhhuzg5 | It raises another critical question"can we find drug targets that by catalytic mechanism are capable of escaping mutation- based drug resistance? |
cord-280158-3fhhuzg5 | Structure based drug design has yielded therapeutics in other areas including HIV/ AIDS( protease inhibitors), antivirals( zanamivir for influenza), and even inhibitors of cyclooxygenase, so why not for antibacterials? |
cord-280158-3fhhuzg5 | The failure of success? |
cord-280158-3fhhuzg5 | We have to ask"how much are we willing to invest in order to get one new antibiotic to the clinic? |
cord-280158-3fhhuzg5 | What does"antibiotic like"really mean anyway? |
cord-280158-3fhhuzg5 | Where Do We Go? |
cord-280158-3fhhuzg5 | Where to uncover? |
cord-280158-3fhhuzg5 | Who will develop new antibacterial agents? |
cord-280158-3fhhuzg5 | With scarce resources and many suggestions for how to find next generation antibiotics, where do you place your bets[ 3]? |
cord-281188-0cql96hu | A numbers game: ribosome densities, bacterial growth, and antibiotic- mediated stasis and death Cause and effect in biology Cause and effect in biology revisited: is Mayr's proximate- ultimate dichotomy still useful? |
cord-281188-0cql96hu | But is it worth the effort? |
cord-281188-0cql96hu | Could high- concentration rifampicin kill rifampicin- resistant M. tuberculosis? |
cord-281188-0cql96hu | For example, why do some ribosome- targeting drugs, such as most but not all aminoglycosides, rapidly kill bacteria, whereas others, such as the macrolides, prevent replication and kill at low rates if at all? |
cord-281188-0cql96hu | How antibiotics kill bacteria: new models needed? |
cord-281188-0cql96hu | Is there a unique mechanism by which antibiotics prevent the replication of bacteria? |
cord-281188-0cql96hu | Is this information, which is critical to the clinical applications of these drugs, not entirely sufficient? |
cord-281188-0cql96hu | The rate of killing of Escherichia coli by beta- lactam antibiotics is strictly proportional to the rate of bacterial growth Kinetics of antimicrobial activity Mechanisms of antimicrobial action of antiseptics and disinfectants: an increasingly important area of investigation Bacterial target sites for biocide action Antibiotic combinations: should they be tested? |
cord-281188-0cql96hu | What are the causes of death? |
cord-281188-0cql96hu | What does the relationship between the concentration of antibiotics and the rate of growth and death of bacteria( that is, pharmacodynamics) tell us about how antibiotics do their bacteriostatic and bactericidal actions? |
cord-281188-0cql96hu | When is a bacterium dead? |
cord-281188-0cql96hu | When, how and why? |
cord-281188-0cql96hu | Why is inhibition of protein synthesis lethal in some cases and only static in others? |
cord-281188-0cql96hu | Why is the loss of cell wall integrity and lysis the result of reduced peptidoglycan biogenesis? |
cord-021158-075vh5jg | ( …) We had developed well in 84- 85, so how could we consolidate our system, how could we really sell it, how could we duplicate it? |
cord-021158-075vh5jg | , Thèse pour le doctorat vétérinaire Challenges facing the farm animal veterinary profession in England: a qualitative study of veterinarians'perceptions and responses Annoying owners: routine interactions with problematic clients in a general veterinary practice Broken biosecurity? |
cord-021158-075vh5jg | And I thought"but this is not the feed from the co- op?". |
cord-021158-075vh5jg | And in this example, what happened in the end? |
cord-021158-075vh5jg | Britain Is prevention better than cure? |
cord-021158-075vh5jg | But are n't you stealing work from the technicians? |
cord-021158-075vh5jg | But what about the economic model on which this kind of expertise is based and how it is actually related to the use of antimicrobials? |
cord-021158-075vh5jg | Could we look beyond the symbols and images of professional and political discourses and see whether these preventive approaches that might change the way veterinary medicine is practiced, and how antibiotics are used, rely on actual knowledge and practices and, if so, where and since when? |
cord-021158-075vh5jg | I even went to Cuba for X. Trying to sell products? |
cord-021158-075vh5jg | Or might you impose sanctions at some point? |
cord-021158-075vh5jg | So at vet school, you did n't think about working with dogs? |
cord-021158-075vh5jg | So the mother was a carrier, so we thought:"what if we use an antiseptic powder?" |
cord-021158-075vh5jg | What does he want? |
cord-021158-075vh5jg | What is the place of animals in the social sciences? |
cord-021158-075vh5jg | Who were you doing this with? |
cord-021158-075vh5jg | Why do veterinarians ask for antimicrobial susceptibility testing? |
cord-021158-075vh5jg | Yet were the farmers prepared to pay for their visits, as they would have done with rural vets at the time? |
cord-021158-075vh5jg | You have suppliers for these products or you manufacture them yourselves? |
cord-021158-075vh5jg | You just let him know, asked him to be careful, and let it go? |
cord-021158-075vh5jg | cord-021158- 075vh5jg authors: Fortané, Nicolas title: Antimicrobial resistance: preventive approaches to the rescue? |
cord-021158-075vh5jg | oder berufener Schützer des Tieres? |